Follow the rules. Understand the workflow. Protect access to care.
NCQA publicly describes an organization-level framework for fair, timely utilization decisions using objective, evidence-based criteria. URAC publicly describes five functional modules and U.S. eligibility conditions. Program fit begins with the legal entity and functions performed, then requires the current licensed standards and official accreditation record.
CMS describes a provisional affirmation as a preliminary finding for a future claim, with item-specific validity, delivery after the decision, and a 14-byte unique tracking number on the claim. Suppliers need one reviewable chain from the authorized item and decision through what was furnished, what was billed, the contractor result, and any correction or resubmission.
DrFirst describes electronic prior-authorization workflows that can answer payer questions from available clinical information. Each proposed answer still needs a traceable source, question version, clinician edit history, submitted value, and payer response before it can support an accountable authorization record.
CMS describes a provisional affirmation as a preliminary finding for a future claim, with item-specific validity, delivery after the decision, and a 14-byte unique tracking number on the claim. Suppliers need one reviewable chain from the authorized item and decision through what was furnished, what was billed, the contractor result, and any correction or resubmission.
DrFirst describes electronic prior-authorization workflows that can answer payer questions from available clinical information. Each proposed answer still needs a traceable source, question version, clinician edit history, submitted value, and payer response before it can support an accountable authorization record.
Latitude Health describes configurable triage rules and AI-powered prioritization for utilization-management intake. A queue priority can direct work, but an expedited-review status needs its own request-specific facts, governing rule, received time, authorized determination, clock, notice, and reclassification history.
Cigna Healthcare’s disclosures index links annual prior-authorization statistics by state and reporting year, including 2025 reports for Illinois and Indiana. A team comparing those files needs the named operating entity, state, product, year, service type, numerator, and denominator before converting a disclosure into a plan-wide performance claim.
The American Medical Association's research page points to physician survey data, qualitative work, and council reports about prior-authorization burden, delays, costs, and workflow disruption. Those materials can identify important experience and reform questions, but a survey percentage is not a payer performance rate or patient-level causal result unless its sampled population, field period, question wording, denominator, weighting, and uncertainty remain visible.
Smile Digital Health says OmniCompli CMS Suite+ uses a unified FHIR and CQL foundation for centralized rule governance and deterministic prior-authorization adjudication. Executable logic can make decisions consistent, but only if each runtime result remains tied to the controlling policy, translated artifact, deployment, request facts, and accountable exception path.
Medical-service authorization moves among benefit rules, clinical records, submission channels, payer or delegate review, determinations, reasons, status, and appeals.
Read the market record →Drug authorization relies on pharmacy-benefit participants and NCPDP transaction paths that should not be silently combined with medical-service workflows.
Read the market record →Operational efficiency and clinical appropriateness are separate questions. Buyers need to see who configures policy, where licensed judgment enters, and how reasons and overrides remain reviewable.
Read the market record →A standard, implementation guide, connector, and production payer connection are different evidence states. The workflow map keeps those boundaries visible.
Read the market record →Pharmacy ePA stakeholders need a version-specific migration, testing, and trading-partner readiness plan distinct from medical-service FHIR implementation.
Coverage-criteria provenance, delegation records, version control, and regulator-ready exports become more explicit enterprise requirements.
DME suppliers and patient-access teams need code-level, date-specific requirement discovery and must also track supplier exemption status.
Pharmacy ePA networks, payers, PBMs, EHRs, pharmacies, clearinghouses, and FHIR infrastructure providers need a scenario plan that preserves the distinction between current obligations and proposed changes.
Plan-level public disclosures create a new benchmarking input, but files require normalization by entity, population, period, request type, and denominator before comparison.
Provider routing logic and training materials must reflect service, plan, date, and exclusion details rather than a generic payer-to-delegate relationship.
The research connects the provider market, normalized capabilities, authority records, operating domains, and source limitations rather than presenting a score or universal winner.
Read the report →